DekaBank Deutsche Girozentrale’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $223M | Buy |
|
|||||
2025
Q1 | $239M | Sell |
|
|||||
2024
Q4 | $205M | Hold |
|
|||||
2024
Q3 | $233M | Buy |
|
|||||
2024
Q2 | $237M | Buy |
|
|||||
2024
Q1 | $204M | Sell |
|
|||||
2023
Q4 | $206M | Buy |
|
|||||
2023
Q3 | $166M | Buy |
|
|||||
2023
Q2 | $163M | Buy |
|
|||||
2023
Q1 | $141M | Buy |
|
|||||
2022
Q4 | $125M | Buy |
|
|||||
2022
Q3 | $123M | Sell |
|
|||||
2022
Q2 | $131M | Sell |
|
|||||
2022
Q1 | $124M | Buy |
|
|||||
2021
Q4 | $76M | Sell |
|
|||||
2021
Q3 | $63M | Buy |
|
|||||
2021
Q2 | $66.1M | Buy |
|
|||||
2021
Q1 | $63.6M | Buy |
|
|||||
2020
Q4 | $54.7M | Sell |
|
|||||
2020
Q3 | $68.3M | Buy |
|
|||||
2020
Q2 | $17.7M | Buy |
|
|||||
2020
Q1 | $13.7M | Sell |
|
|||||
2019
Q4 | $13.5M | Sell |
|
|||||
2019
Q3 | $39M | Sell |
|
|||||
2019
Q2 | $67M | Buy |
|
|||||
2019
Q1 | $20M | Buy |
|
|||||
2018
Q4 | $16.9M | Sell |
|
|||||
2018
Q3 | $20M | Sell |
|
|||||
2018
Q2 | $20.7M | Sell |
|
|||||
2018
Q1 | $28.5M | Buy |
|
|||||
2017
Q4 | $23.3M | Hold |
|
|||||
2017
Q3 | $23.3M | Sell |
|
|||||
2017
Q2 | $22.6M | Buy |
|
|||||
2017
Q1 | $18.5M | Buy |
|
|||||
2016
Q4 | $12.7M | Sell |
|
|||||
2016
Q3 | $15.6M | Sell |
|
|||||
2016
Q2 | $21.4M | Buy |
|
|||||
2016
Q1 | $18.5M | Buy |
|
|||||
2015
Q4 | $24.6M | Sell |
|
|||||
2015
Q3 | $23.7M | Buy |
|
|||||
2015
Q2 | $22.5M | Buy |
|
|||||
2015
Q1 | $20.8M | Buy |
|
|||||
2014
Q4 | $19.9M | Sell |
|
|||||
2014
Q3 | $19.7M | Sell |
|
|||||
2014
Q2 | $20.5M | Buy |
|
|||||
2014
Q1 | $14.6M | Buy |
|
|||||
2013
Q4 | $13.3M | Buy |
|
|||||
2013
Q3 | $11.7M | Buy |
|
|||||
2013
Q2 | $12.2M | Buy |
|